Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/67216

TítuloTreatments used for obsessive-compulsive disorder-An international perspective
Autor(es)Brakoulias, Vlasios
Starcevic, Vladan
Albert, Umberto
Arumugham, Shyam Sundar
Bailey, Brenda E.
Belloch, Amparo
Borda, Tania
Dell'Osso, Liliana
Elias, Jason A.
Falkenstein, Martha J
Ferrao, Ygor A.
Fontenelle, Leonardo F
Jelinek, Lena
Kalogeraki, Leto
Kay, Brian
Laurito, Luana D.
Lochner, Christine
Maina, Giuseppe
Marazziti, Donatella
Martin, Andrew
Matsunaga, Hisato
Miguel, Euripedes C.
Morgado, Pedro
Mourikis, Irakis
Pasquini, Massimo
Perez Rivera, Rodrigo
Potluri, Sriramya
Reddy, Janardhan Y. C.
Riemann, Brian C.
do Rosario, Maria Conceição
Shavitt, Roseli G.
Stein, Dan J.
Viswasam, Kirupumani
Wang, Zhen
Fineberg, Naomi A.
Palavras-chaveAdult
Antipsychotic Agents
Benzodiazepines
Deep Brain Stimulation
Female
Humans
Internationality
Male
Middle Aged
Obsessive-Compulsive Disorder
Psychosurgery
Serotonin Uptake Inhibitors
antipsychotics
cross-cultural study
pharmacotherapy
selective serotonin reuptake inhibitors
Data2019
EditoraWiley
RevistaHuman Psychopharmacology: Clinical and Experimental
CitaçãoBrakoulias V, Starcevic V, Albert U,et al. Treatments used for obsessive–compulsive disorder—An international perspective.Hum Psychopharmacol Clin Exp.2019;34:e2686.https://doi.org/10.1002/hup.268
Resumo(s)Objective The objective of this study was to characterise international trends in the use of psychotropic medication, psychological therapies, and novel therapies used to treat obsessive–compulsive disorder (OCD). Methods Researchers in the field of OCD were invited to contribute summary statistics on the characteristics of their samples. Consistency of summary statistics across countries was evaluated. Results The study surveyed 19 expert centres from 15 countries (Argentina, Australia, Brazil, China, Germany, Greece, India, Italy, Japan, Mexico, Portugal, South Africa, Spain, the United Kingdom, and the United States) providing a total sample of 7,340 participants. Fluoxetine (n = 972; 13.2%) and fluvoxamine (n = 913; 12.4%) were the most commonly used selective serotonin reuptake inhibitor medications. Risperidone (n = 428; 7.3%) and aripiprazole (n = 415; 7.1%) were the most commonly used antipsychotic agents. Neurostimulation techniques such as transcranial magnetic stimulation, deep brain stimulation, gamma knife surgery, and psychosurgery were used in less than 1% of the sample. There was significant variation in the use and accessibility of exposure and response prevention for OCD. Conclusions The variation between countries in treatments used for OCD needs further evaluation. Exposure and response prevention is not used as frequently as guidelines suggest and appears difficult to access in most countries. Updated treatment guidelines are recommended.
TipoArtigo
URIhttps://hdl.handle.net/1822/67216
DOI10.1002/hup.2686
ISSN0885-6222
e-ISSN1099-1077
Versão da editorahttps://onlinelibrary.wiley.com/doi/abs/10.1002/hup.2686
Arbitragem científicayes
AcessoAcesso restrito UMinho
Aparece nas coleções:ICVS - Artigos em revistas internacionais / Papers in international journals

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
treatments-used-obsessive-compulsive.pdf
Acesso restrito!
573,79 kBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID